DeepCura

AlloArc Nephrology Note (Standard)

SOAP / progress noteNephrologyNote templateAny EHR
Version 1 · Updated November 18, 2026

About this template

Use this template when: any outpatient nephrology visit, new or follow-up, including post-hospital visits, for kidney function, kidney disease, electrolytes, blood pressure, fluid balance, stones, dialysis or transplant care. Writes Chief Complaints, HPI, ROS, Assessment with ICD-10 codes and a plan per code, formatted for any EHR. Designed to document only what the visit and chart support. No physical exam or orders.

Sample note

Sample note · Written by the author · Screened for PHI

Chief Complaints:
Hospital follow-up.
CKD follow-up.
Ankle swelling.
Kidney cyst on CT.
Kidney evaluation before cardiac catheterization.

HPI:
72-year-old male with a past medical history of chronic kidney disease stage 4 due to diabetic kidney disease, type 2 diabetes mellitus, hypertension, coronary artery disease, anemia of chronic kidney disease, secondary hyperparathyroidism of renal origin, and chronic metabolic acidosis, presents to nephrology for hospital follow-up. History is provided by the patient and daughter.

1. HOSPITALIZATION FOLLOW-UP:
- (Record Review)
- Admitted to an outside hospital 10/18/2026 to 10/22/2026 after 4 days of vomiting and diarrhea, during which he continued losartan 50 mg daily, furosemide 40 mg daily, empagliflozin 10 mg daily, and metformin 500 mg twice daily; per daughter, he had also been taking ibuprofen two 200 mg tablets three to four times daily for about 2 weeks for low back pain.
- Admission creatinine 4.12 mg/dL with potassium 6.4 mmol/L and bicarbonate 14 mmol/L 10/18/2026; peak creatinine 4.36 mg/dL 10/19/2026; baseline creatinine 2.3 to 2.4 mg/dL per the discharge summary.
- Kidney ultrasound 10/18/2026 showed no hydronephrosis per the discharge summary.
- Treated with IV normal saline, IV calcium gluconate, IV insulin with dextrose, and sodium zirconium cyclosilicate 10 g for 3 doses; did not require dialysis.
- Discharge diagnoses of acute kidney injury on chronic kidney disease stage 4 due to volume depletion and NSAID use, and hyperkalemia, per the discharge summary; creatinine 2.85 mg/dL and potassium 4.8 mmol/L 10/22/2026.
- Hospitalist held losartan, stopped metformin, resumed empagliflozin, and restarted furosemide at 20 mg daily at discharge, and requested a BMP in 2 weeks with nephrology follow-up for the losartan decision.

- (Today's Visit)
- Vomiting and diarrhea resolved before discharge; eating and drinking normally.
- No ibuprofen since admission; low back pain persists on some days, treated with acetaminophen 500 mg as needed.
- Potassium 5.3 mmol/L 11/06/2026, specimen not hemolyzed, with losartan still held.
- Daughter asks whether the kidney injury could happen again.

2. CHRONIC KIDNEY DISEASE STAGE 4 / TYPE 2 DIABETES:
- Creatinine 2.47 mg/dL, eGFR 27 mL/min/1.73 m2 (CKD-EPI 2021) 11/06/2026 (eGFR 28 08/2026, 33 02/2026); urine albumin-to-creatinine ratio 1,690 mg/g 11/06/2026 (1,240 mg/g 08/2026, 1,860 mg/g 02/2026).
- Kidney failure risk equation (4-variable) 19% at 2 years and 48% at 5 years per the laboratory report 11/06/2026.
- Urine still foamy, as before.
- Losartan 50 mg daily held since the hospitalization; taking empagliflozin 10 mg daily without dizziness or genital infections.
- Lisinopril 20 mg daily stopped in 2022 for cough, after which primary care switched him to losartan; finerenone 10 mg daily stopped 03/2026 for potassium 5.8 mmol/L.
- Hemoglobin A1c 7.4% 10/2026; endocrinology increased insulin glargine from 18 to 22 units nightly 10/29/2026 after metformin was stopped.
- Attended the kidney options class with his daughter 09/2026, taught by the clinic nurse educator. Prefers peritoneal dialysis at home and wants to avoid driving 40 minutes each way to a dialysis center three times a week; daughter lives with him, will help with home treatments, and has a spare room for supplies. No prior abdominal surgery.
- Daughter interested in being evaluated as a living kidney donor.

3. ANKLE SWELLING:
- Swelling of both ankles starting about a week after discharge, worse at night; home weight up about 8 pounds since discharge, with a discharge weight of 84.1 kg 10/22/2026 per the discharge summary.
- Sleeping on 2 pillows instead of 1 and short of breath climbing stairs; denies shortness of breath at rest or waking up short of breath.
- Eats canned soup and deli meat often per daughter.
- Echocardiogram 10/07/2026: LVEF 55-60%, normal right ventricular function, and estimated RVSP 38 mmHg per cardiology.

4. ANEMIA OF CHRONIC KIDNEY DISEASE / IRON DEFICIENCY:
- Hemoglobin 9.1 g/dL 11/06/2026 (9.6 g/dL 08/2026, 10.3 g/dL 02/2026); ferritin 64 ng/mL and transferrin saturation 13% 11/06/2026.
- Stopped ferrous sulfate 325 mg daily, started 08/2026, approximately 3 weeks ago because of constipation.
- More fatigue over the past 2 months, napping every afternoon; denies black stools or blood in the stool.

5. SECONDARY HYPERPARATHYROIDISM OF RENAL ORIGIN:
- Phosphorus 5.4 mg/dL, calcium 8.9 mg/dL, intact PTH 312 pg/mL (186 pg/mL 08/2026), and 25-hydroxyvitamin D 34 ng/mL 11/06/2026 on cholecalciferol 2,000 units daily.
- Itching on the back over the past month; drinks 2 colas a day per daughter.

6. CHRONIC METABOLIC ACIDOSIS:
- Bicarbonate 18 mmol/L 11/06/2026 (20 mmol/L 08/2026) on sodium bicarbonate 650 mg twice daily since 08/2026, taken daily without bloating.

7. HYPERTENSION:
- Home morning blood pressures 138-152/74-86 since discharge with losartan held, on amlodipine 10 mg daily and metoprolol succinate 50 mg daily; denies dizziness on standing.

8. LEFT KIDNEY CYST:
- CT abdomen and pelvis with and without IV contrast 05/14/2026, obtained in the emergency department for abdominal pain: 2.4 cm left upper pole cyst with two thin septations and minimal smooth wall thickening, Bosniak IIF per radiology; the report compares it with kidney ultrasound 03/2024, when the cyst measured 1.1 cm and appeared simple.
- Daughter asks about the cyst; denies flank pain or visible blood in the urine.

9. PREPROCEDURAL KIDNEY EVALUATION:
- Left heart catheterization with possible PCI scheduled 11/24/2026 with cardiology, who requested kidney recommendations before the procedure.
- Creatinine 2.21 mg/dL 05/02/2026 before and 2.26 mg/dL 05/21/2026 after the IV contrast CT 05/14/2026.
- Exertional chest tightness with stairs and hills since 09/2026, not at rest; nuclear stress test 10/14/2026 showed a moderate reversible inferior wall perfusion defect per cardiology.

Review of Systems:
Constitutional: Reports fatigue. Denies fever, chills, or decreased appetite.
Ears/Nose/Mouth/Throat: Denies metallic taste.
Cardiovascular: Reports ankle swelling, orthopnea, and exertional chest tightness. Denies chest tightness at rest.
Respiratory: Reports exertional shortness of breath. Denies shortness of breath at rest or waking up short of breath.
Gastrointestinal: Denies current vomiting or diarrhea, nausea, black stools, or blood in the stool.
Genitourinary: Reports foamy urine. Denies visible blood in urine, flank pain, difficulty urinating, or genital infections.
Musculoskeletal: Reports intermittent low back pain.
Integumentary: Reports itching.
Neurological: Denies dizziness or confusion.

Assessment:
ICD Z92.89-History of recent hospitalization:
ICD N17.9-Acute kidney failure, unspecified:
ICD E87.5-Hyperkalemia:
ICD E11.22-Type 2 diabetes mellitus with diabetic chronic kidney disease:
ICD N18.4-Chronic kidney disease, stage 4 (severe):
ICD I12.9-Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease:
ICD E87.70-Fluid overload, unspecified:
ICD D63.1-Anemia in chronic kidney disease:
ICD D50.9-Iron deficiency anemia, unspecified:
ICD N25.81-Secondary hyperparathyroidism of renal origin:
ICD E87.22-Chronic metabolic acidosis:
ICD N28.1-Cyst of kidney, acquired:
ICD Z01.818-Encounter for other preprocedural examination:

Treatment/Plan:
ICD Z92.89-History of recent hospitalization:

ICD N17.9-Acute kidney failure, unspecified:
- Creatinine 2.47 mg/dL 11/06/2026 after a peak of 4.36 mg/dL; kidney function back to about the pre-hospital level per provider, who attributes the injury to dehydration from vomiting and diarrhea combined with ibuprofen while on losartan.
- Advised avoiding all NSAIDs, including ibuprofen and naproxen; acetaminophen up to 3,000 mg daily for back pain.
- Counseled on sick-day rules; advised holding losartan, furosemide, and empagliflozin and calling the clinic the same day if vomiting or diarrhea prevents keeping fluids down.
- Follow-up in 6 weeks.

ICD E87.5-Hyperkalemia:
- Potassium 5.3 mmol/L 11/06/2026 with losartan held; started patiromer 8.4 g daily in water, taken at least 3 hours apart from other medications, so losartan can be restarted.
- Ordered BMP in 1 week and again 1 week after the losartan restart.

ICD E11.22-Type 2 diabetes mellitus with diabetic chronic kidney disease:
- Urine albumin-to-creatinine ratio 1,690 mg/g 11/06/2026 off losartan; advised restarting losartan for kidney protection at 25 mg daily, down from 50 mg daily before the hospitalization, 48 hours after the cardiac catheterization once the post-procedure labs are reviewed, to avoid restarting it just before contrast.
- Continued empagliflozin 10 mg daily.
- Advised the patient not to resume metformin given eGFR 27 mL/min/1.73 m2.
- Prior therapies tried and failed: lisinopril 20 mg daily (cough); finerenone 10 mg daily (potassium 5.8 mmol/L).
- Endocrinology last seen 10/29/2026; next follow-up January 2027.

ICD N18.4-Chronic kidney disease, stage 4 (severe):
- CKD stage 4 with A3 albuminuria per provider, with eGFR 27 mL/min/1.73 m2 (CKD-EPI 2021) 11/06/2026 and a 2-year kidney failure risk of 19%; started kidney replacement therapy planning now because the planning takes time.
- Kidney replacement therapy options discussed (in-center hemodialysis, home hemodialysis, peritoneal dialysis, kidney transplant, and conservative kidney management); patient elected peritoneal dialysis and declined conservative kidney management.
- Referred to general surgery for peritoneal dialysis catheter planning; placement deferred until closer to the need for dialysis.
- Referred to a transplant center for kidney transplant evaluation; advised that wait time accrues once eGFR is 20 or below and that the evaluation takes months.
- Advised the daughter to contact the transplant center's living donor office for her own evaluation.
- Advised no blood draws, IVs, or PICC lines in the left arm, to preserve veins in case hemodialysis is needed.
- Ordered hepatitis B surface antigen, surface antibody, and core antibody; will start the hepatitis B vaccine series if not immune.
- Referred to the renal dietitian (Maria Esposito, RD) for potassium, phosphorus, and sodium counseling.
- Prior studies: Kidney ultrasound 03/2024: right kidney 10.2 cm, left kidney 10.6 cm, increased cortical echogenicity bilaterally, no hydronephrosis.

ICD I12.9-Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease:
- Home blood pressures 138-152/74-86 since discharge with losartan held; made no other antihypertensive changes, expecting the losartan restart and furosemide increase to lower the readings.
- Continued amlodipine 10 mg daily and metoprolol succinate 50 mg daily.

ICD E87.70-Fluid overload, unspecified:
- 2+ pitting edema to the mid-shins bilaterally and crackles at both lung bases, with clinic weight 88.4 kg; increased furosemide from 20 mg daily to 40 mg twice daily.
- Attributed the fluid overload to the lower furosemide dose since discharge rather than the heart, given LVEF 55-60% on the echocardiogram 10/07/2026.
- Advised daily morning weights, calling for a gain of more than 3 pounds in a day or 5 pounds in a week.
- Advised limiting sodium to less than 2,000 mg daily and cutting back on canned soup and deli meat.
- Advised ED evaluation for shortness of breath at rest or inability to lie flat.

ICD D63.1-Anemia in chronic kidney disease:
- Hemoglobin 9.1 g/dL 11/06/2026, attributed to the kidney disease with iron deficiency per provider; deferred an erythropoiesis-stimulating agent until iron is replaced, and will discuss starting one if hemoglobin remains below 10 g/dL after IV iron.

ICD D50.9-Iron deficiency anemia, unspecified:
- Ferritin 64 ng/mL and transferrin saturation 13% 11/06/2026 after ferrous sulfate was stopped for constipation; ordered iron sucrose 200 mg IV weekly for 5 doses at the infusion center.
- Ordered CBC and iron studies 4 weeks after the final iron dose.
- Background: Colonoscopy 03/2024: no source of blood loss identified per gastroenterology.

ICD N25.81-Secondary hyperparathyroidism of renal origin:
- Intact PTH 312 pg/mL with phosphorus 5.4 mg/dL and calcium 8.9 mg/dL 11/06/2026; started sevelamer carbonate 800 mg three times daily with meals.
- Deferred calcitriol until phosphorus is lower; will reconsider if PTH has not come down.
- Ordered phosphorus, calcium, and PTH in 3 months.

ICD E87.22-Chronic metabolic acidosis:
- Bicarbonate 18 mmol/L 11/06/2026 on sodium bicarbonate 650 mg twice daily; increased to 1,300 mg twice daily.
- Accepted the added sodium from the higher dose despite the fluid overload, given the furosemide increase and daily weights.

ICD N28.1-Cyst of kidney, acquired:
- Ordered renal mass protocol MRI for December 2026, after the cardiac catheterization to space out the two contrast exposures; the MRI contrast used by radiology is acceptable at his kidney function per provider.
- Prior studies: CT abdomen and pelvis with and without IV contrast 05/14/2026: 2.4 cm left upper pole cyst with two thin septations and minimal smooth wall thickening, Bosniak IIF per radiology, previously 1.1 cm and simple-appearing on kidney ultrasound 03/2024 per the report; radiology recommended renal mass protocol MRI in 6 months, due 11/14/2026.

ICD Z01.818-Encounter for other preprocedural examination:
- Kidney risk for left heart catheterization stated as high for kidney injury from contrast, given CKD stage 4 and the acute kidney injury in 10/2026.
- Acceptable to proceed with left heart catheterization from a kidney standpoint given the importance of the cardiac indication.
- Recommended the lowest feasible contrast volume and modest isotonic IV fluids before and after the procedure given the current fluid overload, with the final fluid volume per cardiology.
- Advised holding empagliflozin for 3 days before the procedure and furosemide the morning of the procedure, then resuming furosemide the evening after and empagliflozin once eating normally.
- Ordered BMP 48 to 72 hours after the procedure.
- Recommendations to be sent to cardiology today.

This sample note was written by the template’s author and screened for patient information before publishing. Actual output may vary depending on patient encounter and clinical context.